Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19

por Samuels, Elizabeth A., Khatri, Utsha G., Snyder, Hannah, Wightman, Rachel S., Tofighi, Babak, Krawczyk, Noa
Publicado 2022

Self-reported Xylazine Experiences: A Mixed Methods Study of Reddit Subscribers

por Spadaro, Anthony, Connor, Karen O’, Lakamana, Sahithi, Sarker, Abeed, Wightman, Rachel, Love, Jennifer S, Perrone, Jeanmarie
Publicado 2023

Buprenorphine involvement in opioid overdose deaths: A retrospective analysis of postmortem toxicology in Marion County, Indiana, 2015-2021

por del Pozo, Brandon, Atkins, Danielle, Andraka-Christou, Barbara, Wightman, Rachel, Clark, M H, Huynh, Philip, Ray, Bradley
Publicado 2023

Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island

por Clark, Seth A., Davis, Corey, Wightman, Rachel S., Wunsch, Caroline, Keeler, Lee Ann Jordison, Reddy, Neha, Samuels, Elizabeth A.
Publicado 2021

Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl

por Chambers, Laura C., Hallowell, Benjamin D., Zullo, Andrew R., Paiva, Taylor J., Berk, Justin, Gaither, Rachel, Hampson, Aidan J., Beaudoin, Francesca L., Wightman, Rachel S.
Publicado 2023